Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home

BiotechReality - Information Intelligence System for Biopharma

  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Quarterly Results #Phase 3 Trials #Cancer #Novo Nordisk
Gene Therapy News Research

Newly Developed Gene Editing Tool Shows Promising Results for Treating Diseases with Multiple Mutations

  • By Athulya B S
  • 10 April 2025
gene editing tool

By inserting a complete gene, the technique provides a one-step solution that overcomes the limitations of CRISPR gene editing technology.

Tagged Gene Editing, Gene Therapy, Mutations
Science Life Sciences News

Dire Wolf Returns After 12000 Years By De-Extinction Technology

  • By Ajmal Aseem
  • 9 April 2025
dire wolf

Colossal Biosciences, the business seeking to make extinction optional, has resurrected a prehistoric predator best known for its role in Game of Thrones. Approximately 20 [Read More…]

Tagged De-Extinction, Dire Wolf
Business Healthcare & Pharmaceuticals News

mAb Capture Made Cost Effective and Productive With Cytiva’s Protein A Resins

  • By Ajmal Aseem
  • 8 April 2025
cytiva resins

A one-size-fits-all strategy to protein purification is no longer practicable, given the development and transformation of the mAb market, notably the recent rapid emergence of [Read More…]

Tagged Cytiva, Monoclonal Antibodies, Protein A Resins
Clinical Trials Anti-obesity Drugs Business Healthcare & Pharmaceuticals News

Ozempic® Results from STRIDE Shown to Improve Walking Distance and Quality of Life in Adults With Type 2 Diabetes and Peripheral Artery Disease (PAD)

  • By Athulya B S
  • 7 April 2025
novo nordisk

Novo Nordisk presented the full results of STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial that looked at the effects of once-weekly injectable Ozempic®.

Tagged Novo Nordisk, Ozempic
Regulatory Approval Business Healthcare & Pharmaceuticals News

U.S. FDA Approved Amgen’s UPLIZNA® (INEBILIZUMAB-CDON) for the Treatment of Rare Immune Disorder

  • By Athulya B S
  • 6 April 2025
amgen

IgG4-RD can arise in various organs, causing fibrosis and irreversible organ damage. Understanding how organ damage occurs is key to making an accurate diagnosis of IgG4-RD.

Tagged FDA Approval, INEBILIZUMAB-CDON, Rare Immune Disorder
Research Vaccines

New Vaccination Concept Targets Dangerous Bacteria in the Intestine

  • By Ajmal Aseem
  • 4 April 2025
new vaccination concept

For a long time, scientists have been looking into vaccines against pathogenic bacteria in the bowel, particularly those that drugs have proved ineffective against due to resistance.

Tagged Bacteria, Vaccination
Regulatory Business Healthcare & Pharmaceuticals News

Aldeyra Therapeutics Responds to the U.S. FDA’s Denial of Reproxalap’s NDA Application for Treating Signs and Symptoms of Dry Eye Disease

  • By Ajmal Aseem
  • 3 April 2025
US FDA News

FDA stated in the letter that the NDA “failed to demonstrate efficacy in adequate and well controlled studies in treating ocular symptoms associated with dry eyes”.

Tagged Aldeyra Therapeutics, FDA, Reproxalap
Biochemistry Life Sciences Science

Amino Acids – Properties, Structure and Classes

  • By Athulya B S
  • 2 April 2025
amino acid structure labeled

Amino acids are chemical compounds that act as the basic building blocks for proteins. They perform vital functions in a variety of biological processes and [Read More…]

Tagged Amino Acids
Regulatory Approval Business Healthcare & Pharmaceuticals News

Pfizer’s RSV Lower Respiratory Tract Disease Vaccine ABRYSVO®Approved by European Commission

  • By Ajmal Aseem
  • 1 April 2025
pfizer news

Pfizer Inc (PFI). announced that the European Commission (EC) has amended the marketing authorization for ABRYSVO®, the company’s bivalent respiratory syncytial virus (RSV) prefusion F [Read More…]

Tagged ABRYSVO, Pfizer, RSV
Healthcare & Pharmaceuticals Business News

Abbott’s Voltâ„¢ Pulsed Field Ablation System Receives CE Mark to Treat Patients with Abnormal Heart Rhythms

  • By Editor's Desk
  • 31 March 2025
abbott

AFib affects around 8 million Europeans over the age of 65, and this figure is anticipated to grow over the next 30 years.

Tagged Abbott, Abbott Volt

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Pfizer Q3 2026 Results: Pfizer Raises 2026 Guidance to $62–64 Billion as Launched Products Grow 32%
Business Healthcare & Pharmaceuticals News

Pfizer Q3 2026 Results: Pfizer Raises 2026 Guidance to $62–64 Billion as Launched Products Grow 32%

4 November 20264 November 2026
BiotechReality Business Intelligence Desk
Merck KGaA CDMO Divestment: Lonza to Acquire Life Science CDMO Business for Mid-Triple-Digit Million Euros
Business CDMO Healthcare & Pharmaceuticals News

Merck KGaA CDMO Divestment: Lonza to Acquire Life Science CDMO Business for Mid-Triple-Digit Million Euros

3 November 20263 November 2026
BiotechReality Business Intelligence Desk
AstraZeneca Q3 2026 Results: Total Revenue Rises 7% to $46.9bn as Oncology Leads Growth and FY2026 Guidance Holds
Business Healthcare & Pharmaceuticals News

AstraZeneca Q3 2026 Results: Total Revenue Rises 7% to $46.9bn as Oncology Leads Growth and FY2026 Guidance Holds

1 November 20261 November 2026
BiotechReality Business Intelligence Desk
AbbVie Q3 2026 Results: Skyrizi, Rinvoq and Vraylar Drive $17.404 Billion Revenue as EPS Guidance Rises
Business Healthcare & Pharmaceuticals News

AbbVie Q3 2026 Results: Skyrizi, Rinvoq and Vraylar Drive $17.404 Billion Revenue as EPS Guidance Rises

31 October 202631 October 2026
BiotechReality Business Intelligence Desk
Merck Daejeon Bioprocessing Center Opens With €300 Million Investment to Expand Asia-Pacific Biologics Supply
Biotechnology Business Manufacturing News

Merck Daejeon Bioprocessing Center Opens With €300 Million Investment to Expand Asia-Pacific Biologics Supply

30 October 202630 October 2026
BiotechReality Business Intelligence Desk
Sandoz 2026 Sales Rise 5% at CC as Biosimilars Climb 19%; Core-EBITDA Margin Guidance Upgraded to 23.0-23.5%
Business Healthcare & Pharmaceuticals Manufacturing News

Sandoz 2026 Sales Rise 5% at CC as Biosimilars Climb 19%; Core-EBITDA Margin Guidance Upgraded to 23.0-23.5%

29 October 202629 October 2026
BiotechReality Business Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Senior Product Analyst – Novartis, India
    25 October 2026
  • Rare Disease Medical Science Liaison (MSL) – Amgen, Japan
    20 October 2026
  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026
  • Commercial Product Manager – Centrifuge – ThermoFisher, Singapore & Malaysia
    7 October 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter